UK - NorthStar leads £750,000 Reinnervate investment
NorthStar Equity Investors (NSEI) has led a ТЃ750,000 funding round for biotechnology company Reinnervate.
NSEI provided £550,000 through its Co-Investment fund, with the balance provided by angel investors. CELS (the Centre for Excellence in Life Science) has also provided a loan and consultancy guidance. Durham University-spinout Reinnervate is developing ways to manage the growth and function of cultured cells.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








